The Role of Age in Bone Marrow and Stem Cell Transplants for MDS
Ronald L. Paquette, MD, discusses how age impacts the use of bone marrow and stem cell transplants in patients with myelodysplastic syndrome.
Benefits and Risks of Stem Cell Transplant for Older Patients With MDS
Ronald L. Paquette, MD, discusses the choice of using bone marrow and stem cell transplants as treatment for patients with myelodysplastic syndrome.
GVHD Prophylaxis Expands Graft Source Options for MDS
Ronald L. Paquette, MD, discusses the selection of graft source for bone marrow and stem cell transplants in patients with myelodysplastic syndrome.
Reduced Intensity Conditioning Leads to Less Transplant-Related Mortality for Older Patients With MDS
Ronald L. Paquette, MD, discusses how transplant related morbidity and mortality risks differ between age groups for patients with myelodysplastic syndrome.
Factors Impacting Success of Transplant in Patients With MDS
Ronald L. Paquette, MD, discusses characteristics of myelodysplastic syndrome and how they may impact a patient’s success in undergoing stem cell transplant.